Cargando…
A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)
BACKGROUND: Elevated serum levels of luteinizing hormone and slightly decreased serum levels of testosterone (mild Leydig cell insufficiency) is a common hormonal disturbance in testicular cancer (TC) survivors. A number of studies have shown that low serum levels of testosterone is associated with...
Autores principales: | Bandak, Mikkel, Jørgensen, Niels, Juul, Anders, Lauritsen, Jakob, Kreiberg, Michael, Oturai, Peter Sandor, Helge, Jørn Wulff, Daugaard, Gedske |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494856/ https://www.ncbi.nlm.nih.gov/pubmed/28673265 http://dx.doi.org/10.1186/s12885-017-3456-5 |
Ejemplares similares
-
Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
por: Kreiberg, Michael, et al.
Publicado: (2018) -
Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study
por: Wagner, Thomas, et al.
Publicado: (2019) -
Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
por: Garcia, Sara L, et al.
Publicado: (2020) -
Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
por: Garcia, Sara L., et al.
Publicado: (2023) -
The Danish Testicular Cancer database
por: Daugaard, Gedske, et al.
Publicado: (2016)